Holen Sie sich die Stockscreener-App
34.87
2.62%
0.89
Viking Therapeutics Inc Aktie (VKTX) Neueste Nachrichten
VKTX Stock Steady After-Hours On Positive Obesity Drug Pipeline Progress - Stocktwits
VKTX Stock Draws Fresh Attention Ahead Of Earnings: Wall Street Sees Over 170% Upside As GLP-1 Race Burns Hot - Stocktwits
VKTX Eyes Worst Week Since November As Trial Data Looms — Wall Street Still Sees 200% Upside - Stocktwits
A New GLP-1 Challenger? Early Data Shows Viking's New Obesity Drug Tops Novo Rival - Stocktwits
LLY, NVO Stocks Led May’s GLP-1 Rally — But This Smaller ‘Differentiated Player’ Got A Bold 160% Upside Call - Stocktwits
Viking Therapeutics (NASDAQ:VKTX) Upgraded to Hold at Zacks Research - MarketBeat
Viking Therapeutics (VKTX) Stock Still Looks Pricey With Pipeline Hopes Priced In - simplywall.st
Timothy G. Youngquist 2020 Irrevocable Trust Has $10.61 Million Position in Viking Therapeutics, Inc. $VKTX - MarketBeat
VKTX Stock Outpaces LLY, ALT Ahead Of Earnings – Retail Eyes Breakout Ahead - Stocktwits
Viking Therapeutics, Inc. Revenue Breakdown – NASDAQ:VKTX - TradingView
VKTX Stock On Track For Five Consecutive Days Of Gains — Viking Launches Human Trial For Novel Obesity Drug VK3019 - stocktwits.com
Viking Therapeutics Inc (VKTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
VKTX Stock Has Nearly 300% Wall Street Upside — Is Viking’s Oral Obesity Pill The Next Novo Nordisk-Style Breakout? - Stocktwits
META_TITLE_QUOTE - Yahoo Finance
VKTX Stock Clocks Best Day In Nearly 3 Months On Obesity Pipeline Optimism, Buyout Speculation - stocktwits.com
Viking Therapeutics (VKTX) Edges Higher to $33.19 as Key Resistance Level Comes into FocusZero Gamma Level - Vinanet
Cornerstone Capital Inc. Takes $3.33 Million Position in Viking Therapeutics, Inc. $VKTX - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Viking Therapeutics Inc (VKTX) News, Articles, Events & Latest Updates - Stocktwits
VKTX Stock Rallies After Hours On Optimism Around Company’s Obesity Pipeline - Stocktwits
Viking Therapeutics Inc (VKTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
(VKTX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Viking Therapeutics Moves Closer To Challenging Ozempic With Phase 3 Trial Progress - Stocktwits
Viking Therapeutics Declined in July, and why its Long-Term Prospects are Undiminished - AOL.com
VKTX Maintained by JP Morgan -- Price Target Lowered to $65 - GuruFocus
JPMorgan Chase & Co. Issues Pessimistic Forecast for Viking Therapeutics (NASDAQ:VKTX) Stock Price - MarketBeat
Viking Therapeutics, Inc. (VKTX) Stock Analysis: Potential 169% Upside Amid Strong Buy Ratings - DirectorsTalk Interviews
Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics? - Yahoo Finance
Royal Bank of Canada Decreases Stock Position in Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics, Inc. $VKTX Stake Raised by Dimensional Fund Advisors LP - MarketBeat
Viking Therapeutics Inc (VKTX) Stock News Today - TradingKey
Viking Therapeutics: Mysterious GLP-1 Player With A Key Catalyst Due Q3 (Q2 Earnings Overview) - Seeking Alpha
First Trust Advisors LP Acquires Shares of 105,570 Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Viking Therapeutics, Inc. (VKTX) - DirectorsTalk Interviews
Viking Therapeutics (VKTX) Draws Fresh VK2735 Attention, Is It Still Below Fair Value? - Yahoo Finance
The Bull Case For Viking Therapeutics (VKTX) Could Change Following New Obesity Dosing Ambitions And Fresh Financing – Learn Why - Yahoo Finance
0.86%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):